Letter/Comment
The latest advocacy letters and comments from the American Hospital Association.
The AHA today submitted comments on the Food and Drug Administration’s revised draft guidance on hospital and health system compounding under Section 503A of the Federal Food, Drug, and Cosmetic Act.
On behalf of our nearly 5,000 member hospitals, health systems and other health care organizations; our clinician partners — including more than 270,000 affiliated physicians, 2 million nurses and other caregivers — and the 43,000 health care leaders who belong to our professional membership groups…
AHA's letter of support to Reps. Tom O’Halleran (D-AZ), David McKinley (R-WV), Lucille Roybal-Allard (D-CA), and David Joyce R-OH) for the Student Assisted Vaccination Effort Act (H.R. 5699).
Twenty-five organizations, including the AHA, urge Congress to immediately extend the hold on payment cuts and private payer data reporting period under the Clinical Laboratory Fee Schedule due to the continued COVID-19 public health emergency.
AHA, others urge Congress to prevent sequester, PAYGO cuts.
AHA’s Response to Senate Finance Committee’s Request for Information on Behavioral Health Care In the U.S.
Sens. Mark Kelly, D-Ariz., and Bill Cassidy, R-La., and Reps. Doris Matsui, D-Calif., and David McKinley, R- W.Va., urge the White House to enlist federal agencies to investigate price gouging by nurse staffing agencies, to protect patients in dire need of life saving health care treatment and…
The AHA urges the Department of Health and Human Services’ Office for Civil Rights to quickly initiate rulemaking for a legislative provision (H.R. 7898) enacted by Congress this year to recognize certain recommended security practices when making determinations related to Health Insurance…
As organizations representing hospitals and health systems from across the country, we are writing to ask you to remove the reductions to the Medicaid disproportionate share hospital (DSH) program and uncompensated care pools from H.R. 5376, the Build Back Better (BBB) Act.
AHA comments on recent Medicare Payment Advisory Commission discussions on possible approaches to reducing spending on Part B drugs and biologicals, improving alternative payment models, and revising the hospital wage index.